Role of physicochemical properties in the activation of peroxisome proliferator-activated receptor δ

被引:0
|
作者
Vinícius G. Maltarollo
Paula Homem-de-Mello
Káthia M. Honorio
机构
[1] Universidade Federal do ABC,Centro de Ciências Naturais e Humanas
[2] Universidade de São Paulo,Escola de Artes, Ciências e Humanidades
来源
关键词
Docking studies; Drug design; Metabolic syndrome; Molecular modeling; PPARδ; Theoretical methods;
D O I
暂无
中图分类号
学科分类号
摘要
Current researches on treatments for metabolic diseases involve a class of biological receptors called peroxisome proliferator-activated receptors (PPARs), which control the metabolism of carbohydrates and lipids. A subclass of these receptors, PPARδ, regulates several metabolic processes, and the substances that activate them are being studied as new drug candidates for the treatment of diabetes mellitus and metabolic syndrome. In this study, several PPARδ agonists with experimental biological activity were selected for a structural and chemical study. Electronic, stereochemical, lipophilic and topological descriptors were calculated for the selected compounds using various theoretical methods, such as density functional theory (DFT). Fisher’s weight and principal components analysis (PCA) methods were employed to select the most relevant variables for this study. The partial least squares (PLS) method was used to construct the multivariate statistical model, and the best model obtained had 4 PCs, q2 = 0.80 and r2 = 0.90, indicating a good internal consistency. The prediction residues calculated for the compounds in the test set had low values, indicating the good predictive capability of our PLS model. The model obtained in this study is reliable and can be used to predict the biological activity of new untested compounds. Docking studies have also confirmed the importance of the molecular descriptors selected for this system.
引用
收藏
页码:2549 / 2558
页数:9
相关论文
共 50 条
  • [21] Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
    Nishida, K.
    Kunisada, T.
    Shen, Z. N.
    Kadota, Y.
    Hashizume, K.
    Ozaki, T.
    PPAR RESEARCH, 2008, 2008
  • [22] Peroxisome proliferator-activated receptor γ and atherosclerosis
    Nikolaus Marx
    Current Hypertension Reports, 2002, 4 : 71 - 77
  • [23] Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
    Jean-Charles Fruchart
    Cardiovascular Diabetology, 12
  • [24] The role of peroxisome proliferator-activated receptor gamma in prostate cancer
    Elix, Catherine
    Pal, Sumanta K.
    Jones, Jeremy O.
    ASIAN JOURNAL OF ANDROLOGY, 2018, 20 (03) : 238 - 243
  • [25] Peroxisome proliferator-activated receptor α-independent peroxisome proliferation
    Zhang, Xiuguo
    Tanaka, Naoki
    Nakajuna, Takero
    Kamijo, Yuji
    Gonzalez, Frank J.
    Aoyama, Toshifumi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 346 (04) : 1307 - 1311
  • [26] Role of peroxisome proliferator-activated receptor (PPAR)-α gene in Dyslipidemia
    Rashid, Amir
    Jafar, Sadaf
    Yaqub, Raja Khalid
    RAWAL MEDICAL JOURNAL, 2020, 45 (01): : 54 - 57
  • [27] Role of peroxisome proliferator-activated receptor α in epidermal development in utero
    Schmuth, M
    Schoonjans, K
    Yu, QC
    Fluhr, JW
    Crumrine, D
    Hachem, JP
    Lau, P
    Auwerx, J
    Elias, PM
    Feingold, KR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (06) : 1298 - 1303
  • [28] The role of peroxisome proliferator-activated receptor γ in blood pressure regulation
    Hamblin, Milton
    Chang, Lin
    Zhang, Jifeng
    Chen, Y. Eugene
    CURRENT HYPERTENSION REPORTS, 2009, 11 (04) : 239 - 245
  • [29] Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells
    Zhou, YT
    Shimabukuro, M
    Wang, MY
    Lee, Y
    Higa, M
    Milburn, JL
    Newgard, CB
    Unger, RH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8898 - 8903
  • [30] Role of peroxisome proliferator-activated receptor-γ in hematologic malignancies
    Konopleva, M
    Andreeff, M
    CURRENT OPINION IN HEMATOLOGY, 2002, 9 (04) : 294 - 302